Swiss Re AG
SIX:SREN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swiss Re AG
SIX:SREN
|
CH |
|
Lagardere SA
PAR:MMB
|
FR |
|
Pharma Mar SA
MAD:PHM
|
ES |
|
C
|
CJ Corp
KRX:001045
|
KR |
|
J
|
Jefferson Capital Inc
NASDAQ:JCAP
|
US |
|
5N Plus Inc
F:EMB
|
CA |
|
CITIC Ltd
F:CPF0
|
CN |
|
C
|
Cahya Mata Sarawak Bhd
KLSE:CMSB
|
MY |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
S
|
Swiss Re AG
F:SR9A
|
CH |
|
A
|
AeroVironment Inc
F:JPX
|
US |
Intrinsic Value
Is SREN undervalued or overvalued?
See the intrinsic value estimate for Swiss Re AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SREN looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with SREN’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Swiss Re Does
Swiss Re is one of the world’s largest reinsurers. It sells reinsurance to insurance companies, meaning it takes on part of the risk those insurers do not want to keep on their own books. It also offers some direct insurance and specialty risk services, but its core business is helping other insurers manage large losses from events like natural disasters, accidents, and liability claims.
- Headquarters
- Switzerland CH
- Employees
- 14 522
- IPO date
- May 20, 2011
Swiss Re has no economic moat
Customers can seek comparable coverage from other financially strong insurers rather than depend on Swiss Re alone. Its expertise and reputation help it win business, but do not prevent rivals from competing on price and contract terms.
Read the full moat analysis
The intrinsic value for Swiss Re AG (SREN) under the Base Case is hidden CHF.
Compared with the current market price of 154.35 CHF, the stock appears hidden.